☆ 4.2 Editorial Material

Bisphosphonates pathway

PHARMACOGENETICS AND GENOMICS (2011)

Get Full Text
Add to Collection

Journal

PHARMACOGENETICS AND GENOMICS
Volume 21, Issue 1, Pages 50-53

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FPC.0b013e328335729c

Keywords

alendronate; bisphosphonate; bone diseases; bone mineral density; bone resorption; farnesyl pyrophosphate synthase; mevalonate pathway; pharmacogenomics; osteoporosis; riserdronate

Categories

Biotechnology & Applied Microbiology Genetics & Heredity Pharmacology & Pharmacy

Funding

  1. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374] Funding Source: NIH RePORTER
  2. NIGMS NIH HHS [U01 GM061374-10, UO1GM61374, U01 GM061374] Funding Source: Medline

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.